期刊文献+

骨及软组织炎症性病变的^(31)P MR波谱代谢特征初探 被引量:1

Study of ^(31)P MR spectroscopy metabolic characteristics of bone and soft inflammation
下载PDF
导出
摘要 目的初步探讨活体31P MR波谱(31P MRS)在骨炎症性病变中的代谢特征。方法对32例健康志愿者、26例骨及软组织炎症分别行常规X线、MRI与31P MRS检查,测定波谱中各代谢产物的峰下面积,计算各代谢产物间的比值。统计学采用独立样本t检验,判断炎症组与对照组之间是否存在差异。结果炎症组PDE/β-ATP(2.25±0.39)、Pi/β-ATP(1.52±0.47)明显高于对照组(P均<0.05),但PME/β-ATP(0.18±0.11)值不高;对照组低能磷酸盐(LEP)/总31P代谢物(T31P)(0.10±0.02)、PCr/T31P(0.45±0.03)、ATP/T31 P(0.45±0.03)与炎症组之间差异有统计学意义(P<0.01)。结论组织中PDE和Pi的升高,并不伴PME升高的31P MR波谱代谢特征对骨及软组织病变的初步定性诊断有重要意义。MRS技术与常规X线、MRI相结合,将有助于临床对骨炎症性病变的鉴别。 Objective To explore the value of ^31P magnetic resonance spectroscopy(^31P MRS) of bone and soft inflammation.MethodsRadiography,MRI and ^31P MRS were performed on 22 bone and soft-tissue inflammation patients and 32 healthy volunteers.The spectra were analyzed by measuring the areas under the peaks of various metabolites.The data were analyzed by t test.ResultsAnalysis of the ^31P MRS data suggested differences among theinflammation and the healthy group.The mean of PDE/β-ATP(2.25±0.39)、Pi/β-ATP(1.52±0.47)in inflammation group was higher than the control group(P〈0.05),but the ratio of PME/β-ATP(0.18±0.11)was not increasing.The LEP/ T^31P(0.10±0.02)、PCr/T^31P(0.45±0.03)and ATP/ T^31P(0.45±0.03)ratios in control group were significantly different from the experimental group(P〈0.01).ConclusionThe significant increase of PDE、Pi and no increase of PME intracellular is of great value in diagnosis of bone and soft inflammation.Combined conventional radiography and MRI,^31P MRS would be a simple,non-invasive and effective diagnostic method.
出处 《四川医学》 CAS 2011年第6期937-939,共3页 Sichuan Medical Journal
关键词 软组织 炎症 磁共振波谱学 bone and soft inflammation magnetic resonance spectroscopy
  • 相关文献

参考文献10

  • 1Nobauer I,Uffmann M.Differential diagnosis of focal and diffuse neoplastic diseases of bone marrow in MRI (Review)[J].Eur J Radiol,2005,55(1):2~32.
  • 2Shah N,Sattar A,Benanti M,et al.Magnetic resonance spectroscopy as an imaging tool for cancer:a review of the literature (Review)[J].J Am Osteopath Assoc,2006,106(1).23~27.
  • 3刘宏伟,杨贞振,李传亭,吕玉波.常规MRI与^(31)P MR波谱在骨及软组织肿块中的鉴别诊断价值[J].中华放射学杂志,2006,40(2):198-203. 被引量:13
  • 4王立军,杜湘珂,姜保国.骨及软组织肿瘤的磁共振磷谱研究[J].中华放射学杂志,2000,34(11):727-730. 被引量:15
  • 5Khan SA,Cox U,Hamilton G,et al.In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease:a review of H and P MRS applications (Review)[J].Liver Int,2005,25(2):273~281.
  • 6Solga SF,Horska A,Clark JM,et al.Hepatic 31P magnetic resonance spectroscopy:a hepatologist's user guide(Review)[J].Liver Int,2005,25(3):490~500.
  • 7Oberhaensli RD,Hilton-Jones D,Bore PJ,et al.Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy[J].Lancet,1986,2(8497):8~11.
  • 8Tamopolsky MA,Parise G.Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease[J].Muscle Nerve,1999,22(9):1228~1233.
  • 9李烁,金征宇.^(31)P-MRS在骨骼肌疾病中的临床应用[J].国外医学(临床放射学分册),2006,29(4):277-279. 被引量:2
  • 10Zakian KL,Shukla-Dave A,Meyers P,et al,Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy[J].Cancer Res,2003,63 (24):9042~9047.

二级参考文献41

  • 1Crim JR,Seeger LL,Yao L,et al.Diagnosis of soft-tissue masses with MR imaging:canbenign masses be differentiated from malignant ones? Radiology,1992,185:581-586.
  • 2Ma LD.Magnetic resonance imaging of musculoskeletal tumors:skeletal and soft tissuemasses.Curr Probl Diagn Radiol,1999,28:29-62.
  • 3Kalmar JA,Eick JJ,Merritt CR,et al.A review of applications of MRI in soft tissue andbone tumors.Orthopedics,1988,11:417-425.
  • 4Negendank WG,Crowley MG,Ryan JR,et al.Bone and Soft-Tissue Lesions:diagnosis withcombined H-MR imaging and P-31 MR Spectroscopy.Radiology,1989,173:181-188.
  • 5Moulton JS,Blebea JS,Dunco DM,et al.MR imaging of soft-tissue masses:diagnosticefficacy and value of distinguishing between benign and malignantlesions.AJR,1995,164:1191-1199.
  • 6Daly PF,Lyon RC,Faustino PJ,et al.Phospholipid metabolism in cancer cells monitored by31P NMR spectroscopy.J Biol Chem,1987,262:14875-14878.
  • 7Navon G,Navon R,Shulman RG,et al.Phosphate metabolites in lymphoid,Frienderythroleukemia,and HeLa cells observed by high-resolution 31P nuclear magneticresonance.Proc Natl Acad Sci U S A,1978,75:891-895.
  • 8Sostman HD,Prescott PM,Dewhirst MW,et al.MR imaging and spectroscopy for prognosticevaluation in soft-tissue sarcomas.Radiology,1994,190:269-275.
  • 9Shinkwin MA,Lenkinski RE,Daly JM,et al.Integrated magnetic resonance imaging andphosphorus spectroscopy of soft tissue tumors.Cancer,1991,67:1849-1458.
  • 10Redmond OM,Stack JP,O′Connor NG,et al.31P MRS as an early prognostic indicator ofpatient response to chemotherapy.Magn Reson Med,1992,25:30-44.

共引文献19

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部